Table A1.
Variable | GSO | CO | CNO | p |
---|---|---|---|---|
Hepatic FA (mg/g) | ||||
C8:0 | 0.25 ± 0.04 | 0.18 ± 0.10 | 0.16 ± 0.05 | 0.11 |
C10:0 | 0.08 ± 0.04 | 0.06 ± 0.03 | 0.09 ± 0.01 | 0.36 |
C15:0 | 0.22 ± 0.03 | 0.20 ± 0.02 | 0.20 ± 0.03 | 0.49 |
C18:0 | 14.96 ± 2.37 | 13.25 ± 1.48 | 14.14 ± 0.58 | 0.29 |
C20:0 | 0.07 ± 0.02 | 0.11 ± 0.02 | 0.07 ± 0.07 | 0.16 |
C15:1 | 0.13 ± 0.03 | 0.11 ± 0.02 | 0.13 ± 0.03 | 0.57 |
C17:1 | 0.45 ± 0.16 | 0.50 ± 0.09 | 0.44 ± 0.05 | 0.68 |
C20:1 | 0.24 ± 0.02 | 0.27 ± 0.03 | 0.24 ± 0.12 | 0.75 |
C18:2n3 | 0.43 ± 0.12 | 0.49 ± 0.15 | 0.34 ± 0.12 | 0.19 |
C22:5n3 | 0.39 ± 0.10 | 0.41 ± 0.10 | 0.50 ± 0.17 | 0.32 |
Serum TAC | ||||
FRAP (mM TE) | 0.47 ± 0.01 | 0.48 ± 0.02 | 0.46 ± 0.01 | 0.08 |
1 Values are expressed as the mean ± standard deviation, 28-day consumption; 2 grapeseed oil (GSO), corn oil (CO), coconut oil (CNO), ferric reducing ability (FRAP), total antioxidant capacity (TAC).